14.01.2025 - In 2023, business enterprises invested CHF 18 billion in their R&D activities in Switzerland, an annual increase of 3.5% over 2021, which was the last time the survey was carried out. At almost CHF 5.5 billion, the 'pharmaceuticals' sector remains the biggest investor, despite an average annual decline of 6%. Nearly 69 000 people took part in R&D activities, a quarter of them women. These are the main results of a study carried out by the Federal Statistical Office (FSO) in partnership with economiesuisse.
You can find further information such as tables and graphs in the press releases in German, French and Italian. The English version only contains the lead of the press release.
